SAREPTA THERAPEUTICS

Welcome to the Brand page for “SAREPTA THERAPEUTICS”, which is offered here for Pharmaceuticals and pharmaceutical products for treating muscular dystrophy ((, infectious diseases and viruses that respond to ribonucleic acid (rna)-based therapies )) ; pharmaceuticals comprising drugs based on phosphorodiamidate morpholino oligomers technology platform, and drugs that modulate rna expression;therapeutics;medical and scientific research services, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (rna) modulation therapies;.

Its status is currently believed to be active. Its class is unavailable. “SAREPTA THERAPEUTICS” is believed to be currently owned by “SAREPTA THERAPEUTICS, INC.”